» Articles » PMID: 17261663

Mobilization of CD34-positive Bone Marrow-derived Cells After Coronary Stent Implantation: Impact on Restenosis

Overview
Journal Circulation
Date 2007 Jan 31
PMID 17261663
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recently, accumulating evidence has indicated that bone marrow-derived stem cells are capable of differentiating into vascular cells. It has been hypothesized that the inflammatory response after vascular injury triggers the mobilization of endothelial and smooth muscle progenitor cells from bone marrow.

Methods And Results: We measured circulating CD34-positive mononuclear cells, activation of integrin Mac-1 on the surface of neutrophils, and plasma granulocyte-colony stimulating factor levels in 40 patients undergoing coronary stenting. After bare-metal stenting, CD34-positive cells increased, reaching a maximum on day 7 after stenting. The maximum change compared with baseline before stenting was more striking in patients with restenosis than without restenosis (332+/-108% versus 148+/-49%; P<0.05). In contrast, CD34-positive cells decreased after sirolimus-eluting stenting (72+/-21% on day 7). The change in CD34-positive cells on day 7 relative to baseline was closely correlated with that in activated Mac-1 at 48 hours (R=0.52, P<0.01) and that in granulocyte-colony stimulating factor levels at 24 hours (R=0.42, P<0.05). Cell culture assay on day 7 showed that mononuclear cells differentiated into CD31-positive endothelium-like cells after bare-metal stenting. In patients with restenosis, mononuclear cells differentiating into alpha-smooth muscle actin-positive smooth muscle-like cells also were observed. Implantation of sirolimus-eluting stents suppressed both types of differentiation.

Conclusions: Stent implantation may induce differentiation of bone marrow cells into endothelial or smooth muscle cells. Endothelial cells may participate in reendothelialization, a protective reaction against vascular injury, whereas smooth muscle cells may participate in neointimal thickening and restenosis. Sirolimus-eluting stents appear to inhibit the mobilization and differentiation of bone marrow cells.

Citing Articles

Impact of White Blood Cell Count After Percutaneous Coronary Intervention on Long-Term Prognosis in Patients with Unstable Angina Pectoris: A Single-Center Retrospective Observational Cohort Study.

Zhang Z, Wang H, Wang R, She Z, Liang X, Liu H Vasc Health Risk Manag. 2025; 21():25-37.

PMID: 39834485 PMC: 11745057. DOI: 10.2147/VHRM.S492059.


Mobilization of endothelial progenitor cells after implantation of CD34 antibody-covered sirolimus-eluting COMBO stent: assessment with EPC colony-forming assay.

Lu T, Sakuma M, Sohma R, Haruyama Y, Nishino S, Toyoda S Heart Vessels. 2024; .

PMID: 39560718 DOI: 10.1007/s00380-024-02483-6.


Effects of the factor Xa inhibitor rivaroxaban on the differentiation of endothelial progenitor cells.

Sohma R, Sakuma M, Obi S, Nishino S, Inoue K, Kishimoto S BMC Cardiovasc Disord. 2023; 23(1):282.

PMID: 37268884 PMC: 10236699. DOI: 10.1186/s12872-023-03318-4.


Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist).

Gori T Cells. 2022; 11(13).

PMID: 35805178 PMC: 9265311. DOI: 10.3390/cells11132094.


Homing of mRNA-Modified Endothelial Progenitor Cells to Inflamed Endothelium.

Canjuga D, Steinle H, Mayer J, Uhde A, Klein G, Wendel H Pharmaceutics. 2022; 14(6).

PMID: 35745767 PMC: 9229815. DOI: 10.3390/pharmaceutics14061194.